baltimore conference logo
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.

Kimberly L. Blackwell, MD | Authors

Articles

Dr. Kimberly L. Blackwell on a Promising HER2 Breast Cancer Treatment

October 27, 2015

Video

Kimberly L. Blackwell, MD, professor of Medicine, assistant professor of Radiation Oncology, Duke Cancer Institute, discusses upcoming trials for the HER2-antibody margetuximab.